BAMS
TTPH

Bellevue Asset Management (Switzerland)’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$221K Hold
1,100
– – 0.03% 122
2015
Q3 		$164K Buy
1,100
+500
+83% +$367K 0.03% 128
2015
Q2 		$569K Hold
600
– – 0.08% 122
2015
Q1 		$440K Buy
+600
New +$451K 0.06% 135

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s TTPH Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) held its Tetraphase Pharmaceuticals, Inc. (TTPH) position steady in Q4 2015 at 1,100 shares worth $221K. The position accounts for 0.03% of the portfolio, ranked #122.

Bellevue Asset Management (Switzerland) first reported a position in TTPH in Q1 2015 and has held it in 4 quarters since. The position peaked at $569K in Q2 2015. 105 funds tracked by Wall St. Rank hold TTPH as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 1,100 shares of Tetraphase Pharmaceuticals, Inc. worth $221K as of Q4 2015.
  • Bellevue Asset Management (Switzerland) left its Tetraphase Pharmaceuticals, Inc. share count unchanged in Q4 2015.
  • Tetraphase Pharmaceuticals, Inc. made up 0.03% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #122 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2015 and has held it in 4 quarters since.
  • Bellevue Asset Management (Switzerland)'s Tetraphase Pharmaceuticals, Inc. position peaked at $569K in Q2 2015.
  • 105 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.